News Sentiment

STIM sentiment intelligence

Neuronetics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 69 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 1.76 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+24.8% over one week, +32.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM)

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 24.8% Price confirming higher
Trend fit Trend inactive 32.3% over four weeks
Fair value -24.8% Below fair value
Market Dynamics buy signal Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 53
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 12
TradingKey 7
TradingView 5
Quiver Quantitative 3
The Manila Times 2
GlobeNewswire 2
Kavout | AI 1

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 25
Balance sheet 2
Analyst action 2
Deals and strategy 1
Regulatory and legal 1
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 69
Stock Titan Direct company coverage

STIM (NASDAQ) affiliate files to sell 42,164 vested shares via Fidelity

An affiliate of Neuronetics, Inc. (NASDAQ: STIM) has filed a Form 144 notice to sell 42,164 shares of common stock stemming from restricted stock vesting. The proposed transaction is intended for June 8, 2026, and lists Fidelity Brokerage Services LLC as the broker-dealer. The fi

Tone
Neutral 50/100
Event
Market update
Published
08 Jun 2026 22:38
Source
Stock Titan
The Manila Times Direct company coverage

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Neuronetics, Inc. (NASDAQ: STIM) has announced the appointment of Robert Greene as Senior Vice President Sales, effective June 1, 2026. Greene brings extensive experience in commercial strategy and sales leadership within the healthcare and medical technology sectors. In connecti

Tone
Positive 71/100
Event
Market update
Published
03 Jun 2026 07:40
Source
The Manila Times
www.marketscreener.com Direct company coverage

Neuronetics, Inc. Announces Appointment of Robert Greene to Senior Vice President Sales, Effective June 1, 2026

Neuronetics, Inc. has announced the appointment of Robert Greene as its Senior Vice President Sales, effective June 1, 2026. Greene brings extensive experience in leading commercial strategy and sales organizations within the healthcare and medical technology sectors, including c

Tone
Positive 72/100
Event
Market update
Published
03 Jun 2026 06:40
Source
www.marketscreener.com
Stock Titan Direct company coverage

New Neuronetics sales chief gets 200,000-share stock grant

Neuronetics (NASDAQ: STIM) has appointed Robert Greene as its Senior Vice President of Sales, effective June 1, 2026. In connection with his hiring, Greene received an inducement grant of 200,000 restricted stock units (RSUs), vesting in four equal annual installments. This appoi

Tone
Positive 69/100
Event
Market update
Published
02 Jun 2026 20:39
Source
Stock Titan